Merck, Dr. Reddy’s Co-developing Biosimilars


English: Dr Reddy addressing at Patent Symposium

The Merck Serono and Dr. Reddy’s partnership marks the first step by Merck to enter the biosimilar space. The Merck Serono division began exploring the opportunity last year to assess how it could capitalize on its expertise in biopharmaceuticals and its growing presence in key markets including select Emerging Markets.

The headquarter of the Merck Serono division i...

The headquarter of the Merck Serono division in Geneva, which was completed at the end of 2006, offers room for 1.200 employees in research, development and administration. (Photo credit: Wikipedia)

Earlier this year, it set up a dedicated biosimilars unit that will be based in the Canton of Vaud in Switzerland, where the main biologics manufacturing facilities of the division are located.

“The deal structure calls for Merck and Dr. Reddy’s to co-develop the molecules.”

“Dr. Reddy’s will lead early product development and complete Phase I development.”

“Upon completion of Phase I, the Merck Serono division will take over manufacturing of the compounds and will lead Phase III development.”

“The agreement is based on full R&D cost sharing.”

“Merck Serono will undertake commercialization globally, outside the US and with the exception of select emerging markets which will be co-exclusive or where Dr. Reddy’s maintains exclusive rights.”

“At the time of commercialization, Dr. Reddy’s will receive royalty payments from Merck Serono.”

“In the US, the parties will co-commercialize the products on a profit-sharing basis.

The move into biosimilars by Merck Serono is a part of the Merck Group’s transformation program, through a diversified business focused on delivering long-term value and growth opportunities.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: